Inicio > Calidad y desarrollo > Estudios clínicos

ESTUDIOS CLÍNICOS

Metodología


  • Permisos de Construcción

  • Entrega del terreno:

  • Control y Aseguramiento de la Calidad

  • Seguimiento al cumplimiento del Plan de Salud Seguridad e Higiene Ambiental

  • Control de Plazo

  • Control de Costos

  • Comunicaciones

  • Informes:

    • Informes de estado de avance

    • Informe final

  • Reuniones

  • Asuntos Contractuales





LOS TRASTORNOS ARTICULARES INFLAMATORIOS

 

Las afecciones músculo-esqueléticas componen un conjunto de diversas alteraciones que afectan a los músculos, huesos, cartílagos, tendones, ligamentos y otros tejidos conectivos. Dentro de este grupo diverso de afecciones, se encuentran los trastornos articulares inflamatorios, los cuales afectan a los tejidos de la estructura articular [1], [2].

El tratamiento de los trastornos articulares se centra en atenuar el dolor y varía en función de la gravedad de los síntomas experimentados. El tratamiento puede basarse en una combinación de fármacos, descanso, termoterapia y protección de las articulaciones, aunque, en la actualidad, emergen otras opciones terapéuticas con efectos anti-inflamatorios demostrados, tales como la fitoterapia [3].

La osteoartritis es el trastorno articular degenerativo más común y su incidencia es muy elevada entre ancianos, comprometiendo la calidad de vida y pudiendo llegar a representar niveles de discapacidad elevados en este grupo poblacional 

[1], [4].

Los extractos de caracoles son utilizados en numerosas condiciones dermatológicas por sus propiedades antiinflamatorias, calmantes y regeneradoras [7], [8].

Ingrediente que promueve mecanismos de división y regeneración celular 

[13 al 19].

Ingrediente con propiedades anticonceptivas contra el dolor 

[20 al 31].

ALANTOÍNA

 

Ingrediente que modula la respuesta inflamatoria 

[13],[18],[31].


[1] EUMUSC.net, Musculoskeletal Health in Europe Report v5.0. 2013. Disponible en:

http://www.eumusc.net/myUploadData/files/Musculoskeletal%20Health%20in%20Europe%20Report%20v5.pdf. Último acceso Abril 2017.

[2] Palazzo C, Ravaud JF, Papelard A, Ravaud P, Poiraudeau S. The burden of musculoskeletal conditions. PLoS One. 2014;9(3):e90633.

[3] Giannetti BM, Staiger C, Bulitta M, Predel HG. Efficacy and safety of comfrey root extract ointment in the treatment of acute upper or lower back pain: results of a double-blind, randomised, placebo controlled, multicentre trial. Br J Sports Med. 2010;44(9):637-41.

[4] Etgen O, Reginster JY. Degenerative musculoskeletal disease. Ann Rheum Dis. 2004;63:1-3.

[5] Lira Cortés AJ. Determinación de alantoína en secreción de caracol chileno (Helix aspersa Müller). variaciones en su concentración según tipo de alimentación y época de obtención en el año. Tesis de Grado presentada como parte de los requisitos para optar al Título de Químico Farmacéutico. [Fecha de consulta: Marzo 2017] Disponible: http://cybertesis.uach.cl/tesis/uach/2008/fcl768d/doc/fcl768d.pdf [6] Wagge LE. Quantitative studies of Calcium metabolism in Helix aspersa. Quart. J. Mic. Sci. 1951;92:307. [7] Tsoutsos D, Kakagia D, Tamparopoulos K. The efficacy of Helix aspersa Müller extract in the healing of partial thickness burns: a novel treatment for open burn management protocols. J Dermatolog Treat. 2009;20(4):219-22. [8] Min-Jee O, Sung-Min P, Hee-Taek K. The Effects of Snail Secretion Filtrate on the damaged skin barrier's recovery of the Atopic dermatitis. The Journal of Korean Medicine Ophtalmology. 2010;23(3):138-153. [9] Bonnemain B. Helix and Drugs: Snails for Western Health Care From Antiquity to the Present. Evid Based Complement Alternat Med. 2005 Mar; 2(1): 25–28. [10] Staiger C. Comfrey: A Clinical Overview. Phytother Res. 2012; 26(10): 1441–1448. [11] Thompson JE: Topical use of aloe vera derived allantoin gel in otolaryngology. Ear Nose Throat J. 1991;70:56. [12] Conte R. Recent advances on nano delivery of Helix mucus pharmacologically active components. Int. J. Nano Dimens.2016;7 (3):181-185. [13] Ulhôa Araújo L, Grabe-Guimarães A, Furtado Mosqueira VC, Martins Carneiro C, Silva-Barcellos NM. Profile of wound healing process induced by allantoin. Acta Cirúrgica Brasileira. 2010;25(5):460-466. [14] Macalister CJ. Narrative of an investigation concerning an ancient medical remedy and its modern utilities, the Symphytum Officinale and its contained Allantoin. Lee Foundation for Nutritional Research. 1936. [15] Macalister CJ. A new cell proliferant: its clinical application in the treatment of ulcers. The British Medical Journal. 1916;6. [16] Greenbaum FR. Allantoin: A new granulation tissue stimulating substance with especial emphasis on allantoin in ointment form. The American Journal of Surgery. 1936;34(2):259-265. [17] Administración de Drogas y Alimentos de los Estados Unidos (FDA). (2006) Código de Regulaciones Federales 21CFR347 [en línea]. Centro de Dispositivos y Salud Radiológica. FDA. [Fecha de consulta: Abril 2017] Disponible en: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?CFRPart=347&showFR=1 Fecha de última actualización: 1 abril 2007. [18] Temiz C, Temiz P, Sayin M, Ucar K. Effect of cepea extract-heparin and allantoin mixture on epidural fibrosis in a rat hemilaminectomy model. Turkish Neurosurgery. 2009;19( 4):387-392. [19] Loots JM, Loots GP, Joubert WS. The effect of allantoin on cellular multiplication in degenerating and regenerating nerves. S Afr Med J. 1979;55(2):53-6. [20] Madrazo-Jiménez M, Rodríguez-Caballero A, Serrera-Figallo MA, Garrido-Serrano R, Gutiérrez-Corrales A, Gutiérrez-Pérez JL, Torres-Lagares D. The effects of a topical gel containing chitosan, 0,2% chlorhexidine, allantoin and despanthenol on the wound healing process subsequent to impacted lower third molar extraction. Med Oral Patol Oral Cir Bucal. 2016;21(6):e696–e702. [21] Florentino IF, Silva DP, Galdino PM, Lino RC, Martins JL, Silva DM, de Paula JR, Tresvenzol LM, Costa EA. Antinociceptive and anti-inflammatory effects of Memora nodosa and allantoin in mice. J Ethnopharmacol.2016;186:298-304. [22] Kucera M, Kálal J, Polesná Z. Effects of Symphytum ointment on muscular symptoms and functional locomotor disturbances. Adv Therapy. 2000;17:204. [23] Kučera M, Barna M, Horáček O, Kováriková J, Kučera A. Efficacy and safety of topically applied Symphytum herb extract cream in the treatment of ankle distortion: Results of a randomized controlled clinical double-blind study. Wien Med Wochenschr. 2004;154:498. [24] Khoury R. Comfrey Ointment Effective In Treating Ankle Injuries. Journal of the Australian Traditional-Medicine Society. 2005;11(2). [25] Predel H-G, Giannetti B, Koll R, Bulitta M, Staiger C. Efficacy of a Comfrey root extract ointment in comparison to a Diclo-fenac gel in the treatment of ankle distortions: Results of an observer-blind, randomized, multicenter study. Journal of the Australian Traditional-Medicine Society.2005;11(2). [26] Koll R, Buhr M, Dieter R, Pabst H, Predel HG, Petrowicz O, Giannetti B, Klingenburg S, Staiger C. Efficacy and tolerance of a comfrey root extract (Extr. Rad. Symphyti) in the treatment of ankle distorsions: results of a multicenter, randomized, placebo-controlled, double-blind study. Phytomedicine. 2004;11(6):470-7. [27] Kucera M, Barna M, Horàcek O, Kàlal J, Kucera A, Hladìkova M. Topical symphytum herb concentrate cream against myalgia: a randomized controlled double-blind clinical study. Adv Ther. 2005 Nov-Dec;22(6):681-92. [28] Grube B, Grünwald J, Krug L, Staiger C. Efficacy of a comfrey root (Symphyti offic. radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial. Phytomedicine. 2007;14(1):2-10. [29] Smith DB, Jacobson BH. Effect of a blend of comfrey root extract (Symphytum officinale L.) and tannic acid creams in the treatment of osteoarthritis of the knee: randomized, placebo-controlled, double-blind, multiclinical trials. J Chiropr Med. 2011 Sep;10(3):147-56. [30] Giannetti BM, Staiger C, Bulitta M, Predel H-G. Efficacy and safety of a Comfrey root extract ointment in the treatment of acute upper or low back pain: results of a double-blind, randomised, placebo-controlled, multicentre trial. Br J Sports Med. 2010l;44(9):637-41. [31] Lope-Lopez J, Jan-Pallí E, González-Navarro B, Jané-Salas E, Estrugo-Devesa A, Milani M. Efficacy of chlorhexidine, dexpanthenol, allantoin and chitosan gel in comparison with bicarbonate oral rinse in controlling post-interventional inflammation, pain and cicatrization in subjects undergoing dental surgery. Current Medical Research & Opinion. 2015;1–5.

[32] Shen C et al. Dietary polyphenols and mechanisms of osteoarthritis. Journal of Nutritional Biochemistry. 2012;23:1367-77.

[33] Oliviero F et al. Anti-inflammatory effects of polyphenols in arthritis. J Sci Food Agric. 2017 Sep 8. [Epub ahead of print]

[34] Natarajan V et al. Intra-Articular Injections of Polyphenols Protect Articular Cartilage from Inflammation-Induced Degradation:

Suggesting a Potential Role in Cartilage Therapeutics. PLoS One. 2015;10(6):e0127165.

[35] Park SJ et al. Grape-Seed Proanthocyanidin Extract as Suppressors of Bone Destruction in Inflammatory Autoimmune Arthritis. PLOS One. 2012;7(12):e51377.

[36] McGregor G et al. Devil’s Claw (Harpagophytum procumbens): An anti-inflammatory herb with therapeutic potential. Phytochemistry Reviews.2005;4:47-53.

[37] Jang MH et al. Harpagophytum procumbens Suppresses Lipopolysaccharide-Stimulated Expressions of Cyclooxygenase-2 and Inducible Nitric Oxide Synthase in Fibroblast Cell Line L929. J Pharmacol Sci. 2003;93:367-71.

[38] Sanders M et al. The Use of Glucosamine, Devil’s Claw (Harpagophytum procumbens), and Acupuncture as Complementary andVAlternative Treatments for Osteoarthritis. Altern Med Rev.2011;16(3):228-38.

[39] Gagnier JJ et al. Harpgophytum procumbens for osteoarthritis and low back pain: A systematic review. BMC Complementary and Alternative Medicine.2004;4:13.

[40] Chrubasik S et al. Effectiveness of Harpagophytum extract WS 1531 in the treatment of exacerbation of low back pain: a randomized, placebocontrolled, double-blind study. Eur J Anaesthesiol. 1999;16(2):118-29.

[41] Carney SL et al. The structure and function of cartilage proteoglycans. Physiological Reviews. 1988;68(3):858-910.

[42] Martel-Pelletier J et al. Effects of chondroitin sulfate in the pathophysiology of the osteoarthritic joint: a narrative review. Osteoarthritis and Cartilage. 2010;18:7-11.

[43] Richy F et al. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis. A comprehensive meta-analysis. Arch Intern Med. 2003;163:1514-22.

[44] Leeb BF et al. A metaanalysis of chondroitin sulfate in the treatment of osteoarthritis. J Rheumatol. 2000;27:205-11.

[45] Wildi LM et al. Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI. Ann Rheum Dis 2011;70:982-9.

[46] Uebelhart D et al. Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. OsteoArthritis and Cartilage. 2004;12:269-76.

[47] Cooreman WM et al. Bromelain, biochemical and pharmacological properties. Pharm Acta Helv. 1976;51:73-7.

[48] Maurer HR. Bromelain: biochemistry, pharmacology and medical use. Cell Mol Life Sci. 2001;58:1234-45.

[49] Brien S. Bromelain as a Treatment for Osteoarthritis: a Review of Clinical Studies. eCAM. 2004;1(3)251-7.

[50] Pavan R. Properties and Therapeutic Application of Bromelain: A Review. Biotechnology Research International. 2012, Article ID 976203.

[51] Kasemsuk T et al. Improved WOMAC score following 16-week treatment with bromelain for knee osteoarthritis. Clin Rheumatol. 2016;35:2531-40.

[52] Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnesium Trace Elem. 1990;9:61-9.

[53] Hynninen P et al. Chlorophylls. VI. Epimerization and enolization of chlorophyll α and its magnesium-free derivatives. Acta Chemica Scandinavica. 1979;33:637-48.

[54] Roffe C et al. Randomised, cross-over, placebo controlled trial of magnesium citrate in the treatment of chronic persistent leg cramps. Med Sci Monit. 2002; 8(5):CR326-30.

[55] Nagai N et al. Preventive Effect of Water Containing Magnesium Ion on Paw Edema in Adjuvant-Induced Arthritis Rat. Biol. Pharm. Bull.2007; 30(10):1934-7.

[56] Doherty M et al. Double blind, placebo controlled trial of magnesium carbonate in chronic pyrophosphate arthropathy. Ann Rheum Dis. 1983;42(Suppl 1): 106-7.

[57] Aschner JL et al. Nutritional aspects of manganese homeostasis. Molecular Aspects of Medicine. 2005;26:353-62.

[58] Leach RM. Role of manganese in mucopolysaccharide metabolism. Fed Proc. 1971;30(3):991.

[59] Das A Jr et al. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis.Osteoarthritis Cartilage. 2000;8:343-50.

[60] Freeland-Graves J et al. Models to study manganese deficiency. In: Klimis-Tavantzis, D.J. (Ed.), Manganese in Health and Disease. CRC Press, Boca Raton, FL, 1994. pp. 115-20.

[61] Kannus P. Structure of the tendon connective tissue. Scand J Med Sci Sports. 2000;10:312-20.

[62] King JC et al. Zinc Homeostasis in Humans. J. Nutr.2000;130:1360S-66S.

[63] Chasapis CT et al. Zinc and human health: an update. Arch Toxicol. 2012;86:521-34.

[64] Prasad AS. Zinc in Human Health: Effect of Zinc on Immune Cells. Mol Med. 2008;14(5-6):353-7.

[65] Nozaki C et al. Zinc alleviates pain through high-affinity binding to the NMDA receptor NR2A subunit. Nat Neurosci. 2011;14(8):1017-22.

[66] Mattingly PC et al. Zinc sulphate in rheumatoid arthritis. Annals of the Rheumatic Diseases. 1982;41:456-7.

[67] Balogh Z et al. Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis. Annals of the Rheumatic Diseases. 1980;39:329-32.

[68] Simkin PA. Oral zinc sulphate in rheumatoid arthritis. The Lancet. 1976;308(7985):539-42.

[69] Tahiliani AG et al. Pantothenic Acid in Health and Disease. Vitamins & Hormones. 1991;46:165-228.

[70] Bean WB et al. Panthotenic acid deficiency induced in human subjects. J Clin Invest. 1955;34(7 Pt 1): 1073-84.

[71] Nelson MM et al. Changes in endochondral ossification of the tibia accompanying acute pantothenic acid deficiency in young rats. Proc Soc Exp Biol. 1950;73:31-6.

[72] Annand JC. Pantothenie acid and osteoarthritis. Lamed 2. 1963:1168.

[73] General Practitioner Research group. Calcium pantothenate in arthritic conditions. A report from the General Practitioner Research group. Practitioner. 1980;224:208-11.

[74] Iqbal K et al. Biological Significance of Ascorbic Acid (Vitamin C) in Human Health – A Review. Pakistan Journal of Nutrition. 2004;3(1): 5-13.

[75] Blake DR et al. The contribution of hypoxiareperfusion injury to inflammatory synovitis: the influence of reactive oxygen intermediates on the transcriptional control of inflammation. Ann N Y Acad Sci. 1994;723:308-17.

[76] Hall MG et al. The vitamin c requirement in rheumatoid arthritis. Ann Intern Med. 1939;13(3):415-23.

[77] Peterkofsky B. Ascorbate requirement for hydroxylation and secretion of procollagen: Relationship to inhibition of collagen synthesis in scurvy. Am J Clin Nutr. 1991;54(suppl):1135S.

[78] Schwartz ER et al. Effects of ascorbic acid on arysulfatase activities and sulfated proteoglycan metabolism in chondrocyte cultures. J Clin Invest. 1977;60:96-106.

[79] McAlindon TE et al. Do antioxidant micronutrients protect against the development and progression of knee osteoarthritis? Arthritis Rheum. 1996;39(4):648-56.





 

BIBLIOGRAFÍA

GustoPharma Consumer Health S.L.®